Vor Biopharma Inc (NASDAQ:VOR) price on Thursday, March 28, rose 7.24% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.37.
A look at the stock’s price movement, the close in the last trading session was $2.21. The beta value (5-Year monthly) was -0.39. Turning to its 52-week performance, $5.80 and $1.62 were the 52-week high and 52-week low respectively. Overall, VOR moved 9.72% over the past month.
Vor Biopharma Inc’s market cap currently stands at around $161.56 million, with investors looking forward to this quarter’s earnings report slated for May 09, 2024 – May 13, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.38, which has seen fiscal year 2024 EPS growth forecast to increase to -$1.43 and about -$1.3 for fiscal year 2025. Per the data, EPS growth is expected to be 18.30% for 2024 and 9.10% for the next financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was 2 upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that VOR is a 50% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
VOR’s current price about 14.26% and 9.66% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 62.21, while 7-day volatility ratio is 8.08% and 8.55% in the 30-day chart. Further, Vor Biopharma Inc (VOR) has a beta value of -0.38, and an average true range (ATR) of 0.17.
If we refocus on Vor Biopharma Inc (NASDAQ:VOR), historical trading data shows that trading volumes averaged 0.43 million over the past 10 days and 287.61K over the past 3 months. The company’s latest data on shares outstanding shows there are 67.89 million shares.
The 13.54% of Vor Biopharma Inc’s shares are in the hands of company insiders while institutional holders own 76.55% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.07 million on Mar 15, 2024, giving us a short ratio of 7.35. The data shows that as of Mar 15, 2024 short interest in Vor Biopharma Inc (VOR) stood at 4.50% of shares outstanding, with shares short rising to 2.99 million registered in Feb 15, 2024. Current price change has pushed the stock 5.33% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VOR stock continues to rise going into the next quarter.
